Katie Long

Katie Long has extensive experience in the financial industry. Katie began their career in 1998 as a Senior Accountant at Ernst & Young. In 2003, they moved to Credit Suisse as an Assistant Vice President. In 2006, they joined Lloyds TSB as a Senior Manager. Katie then moved to Marwyn in 2008 as an Investment Manager. In 2012, they became a Partner at Tessera Investment Partners. In 2016, they were appointed Chief Financial Officer at Oxford BioDynamics Plc. In 2019, they were appointed Non Executive Director at RazorSecure. Her most recent position is Chief Financial Officer at Celadon Pharmaceuticals Plc, a role they have held since 2021.

Katie Long is a Chartered Accountant (CA) certified by the Institute of Chartered Accountants in Australia. Katie is also a CFA Institute member and holds a Bachelor of Commerce (BCom) from the University of Melbourne.